Starting with anthracyclines, we have expanded our production lines into a series of oncology drugs for different applications, making us a promising player in anti-cancer generic drugs. Other than oncology field, we are also developing into immunosuppressants, specialized antibiotics as well as veterinary API.
With a total plant area of 93,000 m2, we have capabilities in fermentation, DSP and chemical synthesis. All plants were designed and installed under cGMP standards.Our start-of-the-art QC equipment together with strict QA management procedures makes sure that our clients are provided with consistent qualities.
We always value EHS as a foundation of our lasting development. Different measures are taken to protect the environment as well as personnel health and safety. Our aim is to establish an environment-friendly business model for long-term business.
We sincerely hope to partner with international pharmaceutical, chemical and biotech companies for a win-win business.
